EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial Dysfunction Induced by a Novel Salicylate‐Based 1,2,3‐Triazole Salt With Potent Antileishmanial Activity

Bruno A De Oliveira iD, Ari Sérgio de Oliveira Lemos, João Pedro Reis Costa Bastos, Luciana Maria Ribeiro Antinarelli, Ana Luiza Ribeiro de Freitas, Raissa Guedes Mattosinhos Ribeiro, Adolfo Firmino da Silva Neto, Elaine Soares Coimbra iD, Adilson David Da Silva

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Bruno A De Oliveira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Institute of Exact Sciences, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Triazoles, Antiprotozoal Agents, Mitochondria, Salicylates. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leishmaniasis is a neglected disease caused by Leishmania spp., with limited treatment options and no available vaccine. In this study, novel 1,2,3‐triazole derivatives 4‐substituted with salicylic esters and their salts were synthesized and evaluated against L. amazonensis . While neutral compounds were inactive, their salts effectively inhibited both promastigote and intracellular amastigote growth. Compound 7 exhibited the highest antileishmanial activity and selectivity (IC 50 against amastigotes of 6.23 ± 0.35 μM; SI of 17.81), surpassing miltefosine, the positive control. Additionally, this compound exhibited no hemolytic effect. Studies further demonstrated that at early time points (6 h), treatment with compound 7 led to a marked increase in total ROS and mitochondrial superoxide levels, although no change in mitochondrial membrane potential was detected, indicating an initial oxidative imbalance without immediate effects on ΔΨm. However, after 24 h of treatment, this sustained oxidative stress resulted in pronounced mitochondrial membrane potential hyperpolarization, while elevated ROS levels persisted. Throughout these assays, plasma membrane integrity remained unaffected in treated L. amazonensis promastigotes. In silico analyses suggested favorable pharmacokinetic properties and oral bioavailability. Collectively, these findings highlight compound 7 as a promising candidate for further studies, including in vivo assays using murine models of leishmaniasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesAntiprotozoal AgentsMitochondriaSalicylatesLeishmaniaAnimalsMembrane Potential, MitochondrialReactive Oxygen SpeciesMiceOxidative StressMolecular Docking SimulationLeishmaniasis

Stichwörter der Autor:innen

Leishmania amazonensis1,2,3‐triazole derivativesantileishmanial activitymitochondrial dysfunctionoxidative stresssalicylic ester derivatives

Substanzen

TriazolesAntiprotozoal AgentsReactive Oxygen SpeciesSalicylates

Autor:innen und Institutionen

  • Department of Chemistry, Institute of Exact Sciences, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
  • Department of Parasitology, Microbiology and Immunology, Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
  • Department of Veterinary Medicine, Faculty of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.

ORCID-Profile: Bruno A De Oliveira, Elaine Soares Coimbra

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

De Oliveira, B. A., de Oliveira Lemos, A. S., Bastos, J. P. R. C., Antinarelli, L. M. R., de Freitas, A. L. R., Ribeiro, R. G. M., da Silva Neto, A. F., Coimbra, E. S., & Da Silva, A. D. (2025). Mitochondrial Dysfunction Induced by a Novel Salicylate‐Based 1,2,3‐Triazole Salt With Potent Antileishmanial Activity. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70227

Vancouver

De Oliveira BA, de Oliveira Lemos AS, Bastos JPRC, Antinarelli LMR, de Freitas ALR, Ribeiro RGM, et al. Mitochondrial Dysfunction Induced by a Novel Salicylate‐Based 1,2,3‐Triazole Salt With Potent Antileishmanial Activity. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70227

BibTeX
@article{DeOliveira2025,
  author = {De Oliveira, Bruno A and de Oliveira Lemos, Ari Sérgio and Bastos, João Pedro Reis Costa and Antinarelli, Luciana Maria Ribeiro and de Freitas, Ana Luiza Ribeiro and Ribeiro, Raissa Guedes Mattosinhos and da Silva Neto, Adolfo Firmino and Coimbra, Elaine Soares and Da Silva, Adilson David},
  title = {Mitochondrial Dysfunction Induced by a Novel Salicylate‐Based 1,2,3‐Triazole Salt With Potent Antileishmanial Activity},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70227}
}
Kostenlos starten →